Miconal

Miconazole Nitrate, the active ingredient in Miconal, is an imidazole antifungal presented as a vaginal formulation for local use. It is indicated for the treatment of vaginal candidiasis in adult women, targeting the fungal infection that causes itching, discharge, and irritation.

GNH USA supplies Miconal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Miconal is manufactured under EU GMP guidelines and distributed through a secure supply chain.

Miconal, an imidazole antifungal, is used to treat fungal infections of the vaginal tract.

- Vaginal candidiasis: effective treatment of acute infection, relieving itching, discharge, and irritation. - Recurrent vaginal candidiasis: maintenance therapy to reduce frequency of episodes when prescribed by a clinician. - Vulvovaginal candidiasis: alleviation of symptoms associated with yeast overgrowth in the vulvar and vaginal areas.

Miconal may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Vaginal irritation: mild burning or stinging sensation at the site of application. - Itching: localized pruritus that may accompany irritation. - Abnormal discharge: watery or whitish vaginal secretions observed during treatment. - Headache: occasional mild headache reported by some users.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, hives, or angioedema indicating hypersensitivity. - Hepatic dysfunction: rare signs of liver injury such as jaundice, dark urine, or elevated enzymes. - Severe vaginal pain: intense discomfort or ulceration requiring medical evaluation. - Fever: unexplained temperature rise suggesting possible systemic involvement.

Before using Miconal, consider the following precautions. - Allergy assessment: verify patient has no known hypersensitivity to imidazole antifungals. - Active bleeding: avoid use during active vaginal bleeding or trauma. - Duration of therapy: do not exceed prescribed treatment length without medical advice. - Symptom monitoring: seek medical attention if symptoms persist beyond 14 days or worsen. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Miconal can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic azole antifungals: concurrent use may increase systemic exposure and toxicity. - Strong CYP3A4 inhibitors: may elevate local miconazole levels, raising risk of irritation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible minor reduction in efficacy, advise alternative contraception if needed. - Other vaginal products: co‑application may affect absorption or cause irritation. - Antifungal resistance: prolonged use may select for resistant fungal strains.